When I lived in China I spent a month in a village in Sichuan where the economy revolved around huanglian, a root cultivated in the high mountains with medicinal properties. In this week’s Lancet Oncology I reported on how western pharmaceutical companies are trying to tap into the country’s wealth of traditional Chinese medicine for the development of new treatments.